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S Fig 1. P3A8 binding to murine tissue sections.
Images on the left side are stained with Hoechst 33342 for DNA (blue) and labeled with GS-IB4-AF488 for microvessels (magenta) and P3A8-Cy5 (green). Images on the right are labeled as the left except the P3A8 VLR and Cy5 are not chemically conjugated to serve as a negative control. Origin of the tissue sections are labeled for each pair of images. Scale bars = 100 µm.
Supplementi re , 2. , Brain , Parenchymal , ECM , Binding , Clone , P3A8, Demonstrates, Binding, to, Both, Brain, and, Liver, SecBons., 10x$ images$of$murine$0ssue$sec0ons.$Images$on$the$le7$side$are$stained$ with$ Hoechst$ 33342$ for$ DNA$ (blue)$ GSFIB4FAF488$ for$ capillaries$ (magenta)$and$P3A8FCy5$VLR$(green).$Images$on$the$right$are$stained$ as$the$le7$except$the$P3A8$VLR$and$Cy5$are$not$fused$to$serve$as$a$ nega0ve$ control.$ Origin$ of$ the$ 0ssue$ sec0ons$ are$ labeled$ for$ each$ pair$of$images.$Scale$bars$=$100$um.$$ b) Anti-Flag western blot of P1C10-Intein fusion in lane 1 and P1C10 that has undergone EPL to append an azide at the carboxy-terminus in lane 2. c) VLRs are incubated with liposomes that contain DSPE-PEG2000-DBCO. Compared are a no VLR group, a VLR with no chemically reactive carboxy-terminal group, a VLR with a non-DBCO reactive tetrazine at its carboxy-terminus and the VLR with a DBCOreactive azide at its carboxy-terminus. After removal of excess protein, the amount of protein present in each liposome group is quantified using a BCA assay (* p < 0.05 using ANOVA). Supplementary, Figure, 4 ., Characteriza6on, of, Doxorubicin, Loaded, Liposomes., A)" Doxorubicin" loaded" liposomes" were" sized" using" dynamic" light" sca8ering." Formed" liposomes" demonstrated" a" narrow" size" distribu;on" with" mean" diameter" of" 94.2" nm." B)" P1C10" VLR" cloned"into"intein"fused,"yeast"secre;on"vector,"pRS"20208."LeK"lane" demonstrated" VLRLIntein" fusion." Right" line" demonstrates" genera;on" of"P1C10"modified"with"cLterminal"azide"handle"via"EPL."Upper"band" is" nonLmodified" product" and" the" lower" band" is" the" desired" P1C10L Azide" product" C), VLR" with" different" handles" is" incubated" nonL doxorubicin" loaded" liposomes" that" contain" DSPELPEG2000LDBCO." AKer" removal" of" excess" protein," the" amount" of" protein" present" in" each" liposome" group" is" quan;fied" using" a" BCA" assay" (p" <" 0.05," ANOVA)., Amine-PEG3-Azide (Santa Cruz) was conjugated to the c-terminus of Cysteine using FMOC-Cys (Sassrin resin) OH (Bachem) using standard SPPS techniques. The peptide was purified to 90% purity by HPLC and Mass Spectrometry used determine formation of the desired product. Top panel shows the narrow mass range while bottom panel shows wide mass range. Expected mass for Cys-PEG3-Azide is 321 daltons. Supplementary, Figure,5 .,Mass,Spec,traces,for,Manufacture,of,Cys8 PEG38Azide., Amine&Peg3&Azide, (Santa, Cruz), is, conjugated, to, c& terminus, of, Cys, using, FMOC&Cys(Sassrin, resin), OH, (Bachem), using, standard, SPPS, techniques., PepDde, was, purified, to, 90%, purity, by, HPLC, then, Mass, Spectrometry, used, determine, formaDon, of, the, desired,product.,Top,panel,is,narrow,mass,range,while,boNom,panel, is,wide,range.,Expected,mass,is,321,daltons., .
